FLSM
VRNA
Frazier Life Sciences Management’s Verona Pharma VRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320M | Sell |
3,383,950
-73,900
| -2% | -$6.99M | 12.8% | 2 |
|
|
2025
Q1 | $220M | Buy |
3,457,850
+73,900
| +2% | +$4.69M | 10.03% | 3 |
|
|
2024
Q4 | $157M | Hold |
3,383,950
| – | – | 6.52% | 3 |
|
|
2024
Q3 | $97.4M | Buy |
3,383,950
+69,601
| +2% | +$2M | 3.9% | 8 |
|
|
2024
Q2 | $47.9M | Buy |
3,314,349
+300,000
| +10% | +$4.34M | 2.24% | 13 |
|
|
2024
Q1 | $48.5M | Hold |
3,014,349
| – | – | 2.05% | 16 |
|
|
2023
Q4 | $59.9M | Hold |
3,014,349
| – | – | 3.2% | 9 |
|
|
2023
Q3 | $49.1M | Buy |
3,014,349
+70,000
| +2% | +$1.14M | 3.26% | 9 |
|
|
2023
Q2 | $62.2M | Hold |
2,944,349
| – | – | 3.72% | 9 |
|
|
2023
Q1 | $59.1M | Buy |
2,944,349
+128,629
| +5% | +$2.58M | 4.28% | 9 |
|
|
2022
Q4 | $73.6M | Buy |
2,815,720
+716,179
| +34% | +$18.7M | 4.57% | 10 |
|
|
2022
Q3 | $21.5M | Buy |
+2,099,541
| New | +$21.5M | 1.65% | 19 |
|